BIO-key International
BKYI
5 hedge funds and large institutions have $331K invested in BIO-key International in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 5 → 5 (0)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
11% less capital invested
Capital invested by funds: $371K → $331K (-$40K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$29.4K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$12.1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$5.19K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$29K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$6K |
BKYI Hedge Fund Activity: Q2 2019 in Review
5 of the 4,623 institutional investors tracked by Wall St. Rank reported a position in BIO-key International (BKYI) for Q2 2019, worth a combined $331K — down 11% from $371K a quarter earlier.
Fund positioning in BKYI was balanced in Q2 2019: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Perkins Capital Management, opening a new position worth an estimated $29.4K. The largest seller was Citadel Advisors, exiting entirely with an estimated $29K sold.
- 5 institutional investors held BIO-key International (BKYI) as of Q2 2019, unchanged from Q1 2019.
- Funds reported $331K of BIO-key International stock for Q2 2019, down 11% quarter-over-quarter.
- 2 funds opened new BIO-key International positions in Q2 2019 and 2 closed out, a net change of 0 holders.
- The largest BIO-key International buyer in Q2 2019 was Perkins Capital Management, an estimated $29.4K added.
- The largest BIO-key International seller in Q2 2019 was Citadel Advisors, an estimated $29K sold.
Based on aggregated 13F filings for Q2 2019.